Delivery Order SPE2DR25D2204-SPE2DR26FS19F
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $4,049.61 for INGREZZA 60 mg capsules (30-count units) on July 21, 2025, with an ultimate completion date of August 11, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is being fulfilled from the vendor's Conshohocken, Pennsylvania location. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a $11,028.36 delivery order to AmerisourceBergen Drug Corp for INGREZZA 40 MG capsules (30-count units) on August 25, 2025, with completion expected by September 16, 2025. This firm fixed-price contract, which carries no set-aside designation, represents a competitive award to the pharmaceutical distributor's Conshohocken, Pennsylvania location. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $4,049.61 to AmerisourceBergen Drug Corp on May 27, 2025, for the supply of INGREZZA 60 mg capsules (30-count units). This is a firm fixed price delivery order with no set-aside designation, issued competitively under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. The contract specifies a completion date of June 17, 2025, and identifies AmerisourceBergen's Corporate Office in Conshohocken,...
- The Defense Logistics Agency awarded a $7,352.24 delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of INGREZZA 40 mg capsules (30-count units). This competitively awarded, non-set-aside contract is classified as a firm fixed price delivery order with an ultimate completion date of August 19, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the delivery from its corporate office location in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,676.11 to AmerisourceBergen Drug Corp for INGREZZA 40 mg capsules (30-count units) on October 15, 2025, with an ultimate completion date of November 5, 2025. This firm fixed-price, competitively awarded contract (without set-aside designation) represents a purchase of pharmaceutical inventory to support federal medical supply requirements. The place of performance is listed as Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of INGREZZA 80 MG capsules (30-count units) under a firm fixed-price contract with a ceiling value of $8,055.40 and an ultimate completion date of October 17, 2025. This non-set-aside, competitively awarded delivery order represents a routine pharmaceutical procurement supporting federal medical supply needs. The award was issued to AmerisourceBergen's corporate office in...
- The Defense Logistics Agency Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order on July 7, 2025, for INGREZZA 40 mg capsules (30-count units) with a ceiling value of $3,676.12. This competitively awarded, non-set-aside contract operates under a firm fixed-price model with an ultimate completion date of July 28, 2025. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Ingrezza 40 mg capsules (30-count units) valued at $3,676.12. This is a firm fixed-price delivery order with an ultimate completion date of October 20, 2025, and represents a non-set-aside competitive award. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under a larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of INGREZZA 40 mg capsules (30-count units) valued at $3,676.12. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by October 14, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. INGREZZA is a prescription medication used to treat tardive dyskinesia, a...
- The Defense Logistics Agency awarded a $4,049.61 delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Ingrezza 60 mg capsules (30-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 23, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- SPE2DR25D2204Indefinite Delivery Contract
- SPE2DR25D2204-SPE2DR26FS19FDelivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $7,748.14 on November 4, 2025, for the supply of INGREZZA 40 MG capsules (30-count units). This non-set-aside, competitively awarded contract utilizes firm fixed pricing and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of November 26, 2025. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement needs, particularly supporting military and veteran healthcare systems. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling supply of a broad range of pharmaceutical products and medical commodities across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This specific delivery order for INGREZZA, a neurological treatment medication, exemplifies the company's role in fulfilling specialized pharmaceutical requirements within the Defense Logistics Agency's medical supply chain operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.7k | 11/4/25 |